SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-15-060962
Filing Date
2015-07-15
Accepted
2015-07-15 17:38:44
Documents
1
Period of Report
2015-07-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6091
  Complete submission text file 0001209191-15-060962.txt   8609
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address
ISALY SAMUEL D (Reporting) CIK: 0001055949 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37490 | Film No.: 15990044

Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Reporting) CIK: 0001055951 (see all company filings)

State of Incorp.: DE
Type: 3 | Act: 34 | File No.: 001-37490 | Film No.: 15990045

Mailing Address 46701 COMMERCE CENTER DRIVE PLYMOUTH MI 48170
Business Address 46701 COMMERCE CENTER DRIVE PLYMOUTH MI 48170 734-233-3966
ProNAi Therapeutics Inc (Issuer) CIK: 0001290149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CORPORATION SERVICE COMPANY 2711 CENTERVILLE ROAD, SUITE 400 WILMINGTON DE 19808
Business Address C/O ORBIMED ADVISORS LLC 601 LEXINGTON AVENUE, 54TH FLOOR NEW YORK NY 10022 212-739-6400
OrbiMed Private Investments V, LP (Reporting) CIK: 0001589316 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37490 | Film No.: 15990043